Literature DB >> 7842090

[Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].

M David1, M Sempé, M Blanc, M Nicolino, M G Forest, Y Morel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7842090

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


× No keyword cloud information.
  6 in total

Review 1.  Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.

Authors:  D Merke; M Kabbani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Growth in congenital adrenal hyperplasia.

Authors:  An Tt Nguyen; Justin J Brown; Garry L Warne
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

3.  Final adult height in children with congenital adrenal hyperplasia treated with growth hormone.

Authors:  Karen Lin-Su; Madeleine D Harbison; Oksana Lekarev; Maria G Vogiatzi; Maria I New
Journal:  J Clin Endocrinol Metab       Date:  2011-03-30       Impact factor: 5.958

4.  Validation of automatic bone age determination in children with congenital adrenal hyperplasia.

Authors:  David D Martin; Katharina Heil; Conrad Heckmann; Angelika Zierl; Jürgen Schaefer; Michael B Ranke; Gerhard Binder
Journal:  Pediatr Radiol       Date:  2013-10-05

5.  Growth and reproductive outcomes in congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-01

6.  Management of 21-hydroxylase deficiency congenital adrenal hyperplasia: A survey of Canadian paediatric endocrinologists.

Authors:  Robert Stein; Diane Wherrett; Denis Daneman
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.